Tower Research Capital (TRC)’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.47K | Sell |
2,478
-5,871
| -70% | -$8.22K | ﹤0.01% | 4491 |
|
2025
Q1 | $13.4K | Sell |
8,349
-1,198
| -13% | -$1.93K | ﹤0.01% | 3365 |
|
2024
Q4 | $12K | Buy |
9,547
+5,569
| +140% | +$7.02K | ﹤0.01% | 3661 |
|
2024
Q3 | $7.48K | Sell |
3,978
-1,285
| -24% | -$2.42K | ﹤0.01% | 4047 |
|
2024
Q2 | $38.9K | Buy |
5,263
+2,915
| +124% | +$21.6K | ﹤0.01% | 3288 |
|
2024
Q1 | $18.4K | Buy |
2,348
+250
| +12% | +$1.96K | ﹤0.01% | 3074 |
|
2023
Q4 | $10.7K | Sell |
2,098
-284
| -12% | -$1.44K | ﹤0.01% | 4218 |
|
2023
Q3 | $14.1K | Buy |
2,382
+1,403
| +143% | +$8.31K | ﹤0.01% | 3711 |
|
2023
Q2 | $7.26K | Buy |
979
+643
| +191% | +$4.77K | ﹤0.01% | 4571 |
|
2023
Q1 | $3K | Sell |
336
-100
| -23% | -$893 | ﹤0.01% | 5169 |
|
2022
Q4 | $5K | Sell |
436
-4,129
| -90% | -$47.4K | ﹤0.01% | 4834 |
|
2022
Q3 | $33K | Sell |
4,565
-1,241
| -21% | -$8.97K | ﹤0.01% | 3514 |
|
2022
Q2 | $28K | Buy |
5,806
+4,771
| +461% | +$23K | ﹤0.01% | 3431 |
|
2022
Q1 | $6K | Buy |
1,035
+133
| +15% | +$771 | ﹤0.01% | 4848 |
|
2021
Q4 | $5K | Buy |
902
+702
| +351% | +$3.89K | ﹤0.01% | 5128 |
|
2021
Q3 | $2K | Sell |
200
-3,608
| -95% | -$36.1K | ﹤0.01% | 5231 |
|
2021
Q2 | $30K | Buy |
3,808
+1,897
| +99% | +$14.9K | ﹤0.01% | 3476 |
|
2021
Q1 | $15K | Buy |
+1,911
| New | +$15K | ﹤0.01% | 4091 |
|
2020
Q4 | – | Sell |
-1,481
| Closed | -$14K | – | 5116 |
|
2020
Q3 | $14K | Buy |
1,481
+321
| +28% | +$3.03K | ﹤0.01% | 3955 |
|
2020
Q2 | $12K | Buy |
+1,160
| New | +$12K | ﹤0.01% | 3919 |
|
2015
Q4 | – | Sell |
-247
| Closed | -$13K | – | 4454 |
|
2015
Q3 | $13K | Sell |
247
-327
| -57% | -$17.2K | ﹤0.01% | 2081 |
|
2015
Q2 | $45K | Buy |
574
+551
| +2,396% | +$43.2K | ﹤0.01% | 1447 |
|
2015
Q1 | $2K | Sell |
23
-298
| -93% | -$25.9K | ﹤0.01% | 3722 |
|
2014
Q4 | $57K | Buy |
321
+65
| +25% | +$11.5K | 0.01% | 954 |
|
2014
Q3 | $51K | Buy |
256
+218
| +574% | +$43.4K | 0.01% | 1512 |
|
2014
Q2 | $8K | Buy |
+38
| New | +$8K | ﹤0.01% | 2501 |
|